Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis
|
|
- Damian Franklin
- 5 years ago
- Views:
Transcription
1 Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis Neal D. Kon, MD,* Robert D. Riley, MD, Sandy M. Adair, RN, Dalane W. Kitzman, MD, and A. Robert Cordell, MD Department of Cardiothoracic Surgery and Section of Cardiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina Background. Stentless porcine aortic valves offer several advantages over traditional valves. Among these are superior hemodynamics, laminar flow patterns, lack of need for anticoagulation, and perhaps improved durability. Methods. One hundred four patients were operated on from September 17, 1992, to October 31, 1997, as part of a multicenter worldwide investigation of the Medtronic Freestyle stentless porcine bioprosthesis. All patients received a total aortic root replacement. The patients were evaluated postoperatively at discharge, at 3 to 6 months, and yearly by clinical examination and color flow Doppler echocardiography. Results. Operative mortality was 3.9%. No patient experienced structural valve deterioration, nonstructural deterioration, perivalvular leak, or unacceptable hemodynamic performance. At 8 years, survival was 59.8%. Freedom from thromboembolic complications was 83.3%. Freedom from postoperative endocarditis was 96.9%. Freedom from reoperation was 100%. Mean systolic gradients did not change over the time period studied. They were mm Hg at 1 year and mm Hg at 8 years. Correspondingly, effective orifice area was cm 2 at 1 year and cm 2 at 8 years. The incidence of any aortic insufficiency also did not change over the length of follow-up. At 1 year, 98% of patients had no or trivial aortic insufficiency and 2% had mild aortic insufficiency. At 8 years, 100% of patients evaluated were free of any aortic insufficiency. Conclusions. The Medtronic Freestyle aortic root bioprosthesis can be used safely to replace the aortic root or aortic valve for aortic valve and aortic root pathology. Total root replacement allows optimal hemodynamic performance with no significant aortic regurgitation. Results up to 8 years show excellent survival and no signs of degeneration. Further follow-up is still needed to determine valve durability. (Ann Thorac Surg 2002;73: ) 2002 by The Society of Thoracic Surgeons Stentless porcine aortic valves offer superior hemodynamic performance when compared to their stented counterparts [1]. Flow patterns are remarkably similar to normal native aortic valves [2]. In addition, they are silent, do not require the use of anticoagulants, and, in an elderly population, promise suitable durability. The greatest drawback to the use of stentless porcine aortic valves appears to be the technical demands associated with implantation [3]. Various techniques have been described, but are often associated with longer ischemic times and a surgeon s fear of aortic valvular incompetence at the conclusion of the operation [4, 5]. Similar technical difficulties and fears were observed with the use of aortic allografts. Many surgeons adopted the use of a root replacement technique to ensure aortic Presented at the Forty-eighth Annual Meeting of the Southern Thoracic Surgical Association, San Antonio, TX, Nov 8 10, *Recipient of the 2001 Southern Thoracic Surgical Association President s Award. Address reprint requests to Dr Kon, Department of Cardiothoracic Surgery, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC ; nkon@wfubmc.edu. valve competence when using an aortic allograft [6, 7] or pulmonary autograft [8, 9]. Therefore, we preferentially chose the full root technique when we began implanting stentless porcine valves in The present study evaluates our results with the initial Food and Drug Administration trial population of Medtronic Freestyle aortic root bioprosthesis during the past 8 years. Patients and Methods Wake Forest University Baptist Medical Center was selected in 1992 to serve as one of the US study centers to begin implanting the Freestyle investigational valve. Before initiation of the study at our center, the institution s internal review board approved the study design. Written informed consent was obtained for each patient before operation. This study evaluates the 104 total aortic root replacements submitted from our institution as part of Medtronic, Incorporated s submission to the Food and Drug Administration (FDA) for premarket approval of this valve. These 104 patients also make up a part of Medtronic s postmarket approval study required by the 2002 by The Society of Thoracic Surgeons /02/$22.00 Published by Elsevier Science Inc PII S (02)
2 1818 KON ET AL Ann Thorac Surg EIGHT-YEAR RESULTS WITH FREESTYLE PORCINE ROOT 2002;73: Table 1. Distribution of Valve Size Implanted Valve Size All Patients (n 104) No. Implanted % of Total 19 mm 6 5.8% 21 mm % 23 mm % 25 mm % 27 mm % Table 3. Incidence of Concomitant Procedure Procedures No. % of Total Coronary artery bypass % Ascending aorta replacement/repair % Myomectomy 3 2.9% Isolated aortic root replacement % Patients may have more than one concomitant procedure. Food and Drug Administration at the time of approval for general use. From September 17, 1992, to October 31, 1997, 104 patients received a Freestyle aortic root bioprosthesis. Forty-seven of the patients (45%) were men and 57 (55%) were women. The mean age was 72 years, with a range of 48 to 87 years. Eighty-seven percent of the patients were more than 65 years old and 77% were in New York Heart Association functional class III or IV preoperatively. All five available sizes were implanted (19, 21, 23, 25, and 27 mm). The distribution of use is shown in Table 1. Table 2 lists the various preoperative risk factors in this elderly patient population. The incidence of performing a concomitant procedure is listed in Table 3. The freestanding total aortic root replacement technique was chosen in all 104 patients. We have previously described the details of this technique [10]. Valve rotation was not performed at any of the operations in this group. All available patients were evaluated at discharge, at a 3- to 6-month interval, and again yearly by clinical examination and color flow Doppler echocardiography. Preoperative and postoperative data at each clinical examination and at each echocardiographic evaluation Table 2. Preoperative Risk Factors (n 104) Risk Factors a All Patients %of Total History of chronic lung airway disease % Diabetes mellitus % Myocardial infarction 6 5.8% Carotid artery disease 8 7.7% History of TIA CVA % Multiple occurrences 3 2.9% TIA CVA thrombotic TIA CVA hemorrhagic 1 1.0% TIA CVA embolic 1 1.0% TIA CVA indeterminate 7 6.7% Coronary artery disease % History of arrhythmias % Atrial arrhythmias % Ventricular arrhythmias 9 8.7% Congestive heart failure % Left ventricular dysfunction % Hypertrophy % Dilation % History of endocarditis 1 1.0% a Patients may have more than one risk factor. were tabulated and placed in the Freestyle database at Medtronic, Incorporated, in Minneapolis, Minnesota. Descriptive statistics were used to summarize the preoperative, operative, follow-up clinical, and hemodynamic data. The number of patients, mean, and standard deviation are provided for categorical data. The life table method is used to estimate survival and freedom from adverse events. Results Initial patient improvement in New York Heart Association functional class for congestive heart failure after operation is shown in Table 4. Mean aortic cross-clamp times for patients with isolated aortic root replacement were 110 minutes, whereas those who also had an additional concomitant procedure were minutes. Operative mortality (30-day or in hospital) was 3.9%. The actuarial survival rate at 8 years was 59.8% (Fig 1). Freedom from aortic valve reoperation and freedom from structural valve deterioration at 8 years were both 100%. The freedom from postoperative endocarditis at 8 years was 96.9% (Fig 2), whereas freedom from thromboembolic complications at 8 years was 83.3% (Fig 3). No patient suffered clinical hemolysis, nonstructural dysfunction, or unacceptable postoperative hemodynamic performance of the Freestyle aortic valve. The mean aortic valve gradients and effective orifice areas for each valve size are shown in Table 5. The mean aortic valve gradient and effective orifice areas for all sizes combined at each follow-up interval are shown in Table 6. There was no significant change in valve gradient or orifice area overall or for any size from the time of implant throughout the entire 8-year follow-up period. No patient exhibited any significant aortic regurgitation at any time interval studied for 8 years postoperatively (Fig 4). There were no observable changes in aortic valve function during the 8 years. Table 4. Change in NYHA Class From Preoperative NYHA Class Preoperative No. of Patients (%) 3 6 mo Postoperative No. of Patients (%) I 2 (1.9%) 94 (96.9%) II 22 (21.2%) 2 (2.1%) III 69 (66.3%) 1 (1.0%) IV 11 (10.6%) NYHA New York Heart Association.
3 Ann Thorac Surg KON ET AL 2002;73: EIGHT-YEAR RESULTS WITH FREESTYLE PORCINE ROOT 1819 Fig 1. The linearized rate of freedom from death after aortic root replacement. The open circles represent the estimated survival for 72-year olds in the United States in The data are from the National Vital Statistics Report, Vol. 47, No. 28, December 13, The vertical line is 95% confidence interval of survival for the Freestyle patients. Comment Aortic valve replacement with stentless porcine bioprostheses as a group has been associated with excellent hemodynamics and excellent clinical outcomes [11 14]. As has been described for aortic valve replacement with aortic allografts and pulmonary autografts, the Freestyle stentless porcine aortic root bioprosthesis can be implanted using one of several surgical techniques: the complete or modified subcoronary technique, the root inclusion technique, or a free-standing total aortic root replacement technique. When the multicenter clinical evaluation of the Freestyle stentless porcine aortic root bioprosthesis began in 1992, we elected to use the free-standing total aortic root replacement technique. This stentless aortic valve replacement technique was chosen for all patients with either aortic valve or aortic root pathology. It was our belief at the time, and has been subsequently demonstrated that this technique offers the best hemodynamic performance and the Fig 2. The linearized rate of freedom from endocarditis after aortic root replacement. Fig 3. The linearized rate of freedom from thromboembolic events after aortic root replacement. lowest incidence of aortic regurgitation when compared to other implantation techniques [4, 15]. The anticipated disadvantages of the full root replacement technique include prolonged myocardial ischemic times and increased intraoperative bleeding complications. Several lessons have been learned with our experience during the past 8 years using the Freestyle valve. Myocardial ischemic times have not been sufficiently prolonged to result in increased morbidity or mortality. Some previous studies have demonstrated longer ischemic times for root replacement than for the modified subcoronary technique [4, 15], whereas other studies have shown similar cross-clamp times for the two techniques [14, 16]. An aortic root replacement with a stentless valve involves an inflow suture line, two coronary artery reimplantation suture lines, and an aortic reapproximation suture line. A stented aortic valve replacement involves only an inflow suture line and an aortic closure suture line in the uncomplicated situations. Thus, in most instances, a stented valve is quicker to implant. Therefore, although a stentless root replacement may be similar in operative time to a stentless subcoronary implant, it is in no way as quick as a valve replacement with a stented valve. This has not, however, resulted in increased morbidity or mortality. We have also not seen a difference in bleeding complications despite the increased number of suture lines and operative complexity. The root replacement technique most reliably maintains root geometry for the stentless porcine leaflets. This is documented not only by studies showing the least incidence of aortic insufficiency with this technique, but also by having the lowest early gradients [4]. Late follow-up in this study, up to 8 years, shows no increase in gradients, no decrease in effective orifice area, and no increase in the incidence of aortic insufficiency over time. In contrast, a recent study evaluating the late follow-up for the Toronto stentless porcine valve, implanted with the subcoronary technique, has been associated with progressive dilatation of the sinotubular junction resulting in increased incidence of aortic insufficiency [17]. Other studies from the Freestyle database have shown somewhat more favorable hemodynamics, a lower pre-
4 1820 KON ET AL Ann Thorac Surg EIGHT-YEAR RESULTS WITH FREESTYLE PORCINE ROOT 2002;73: Table 5. Mean Systolic Gradient and Effective Orifice Area After Aortic Root Replacement Mean systolic Gradient (mmhg) Effective Orifice Area (cm 2 ) Discharge 2 yrs 5 yrs 7 yrs Discharge 2 yrs 5 yrs 7 yrs 19 mm (No.) Mean/SD mm (No.) Mean/SD mm (No.) Mean/SD mm (No.) Mean/SD mm (No.) Mean/SD valence of aortic insufficiency, and better New York Heart Association functional class on follow-up with the full root technique [18]. Utilization of the root replacement technique with aortic allografts also has been associated with greater durability when compared to the other implant techniques [19]. Another question regarding porcine root replacement concerns the fate of the aortic wall over time. In this study, we have routinely asked our echocardiographer to pay special attention to this detail. In no patient has excess aortic wall calcification been noted. Melina and associates [20] have compared aortic wall calcification in the Freestyle root to the aortic wall calcification in aortic allograft root replacements. Thus far calcification has remained lower in the Freestyle aortic wall than in the allograft aortic wall. No significant changes in the elastic properties of the aortic wall have been observed. Coronary orientation has posed some problems with aortic root replacement with Freestyle. The human coronaries are generally 120 to 160 apart, whereas the porcine coronaries are generally 90 to 110. The right porcine coronary artery sits in a superior plane compared to the left porcine coronary artery, and the Dacron inflow of the Freestyle valve comes up higher under the porcine right coronary artery than it does over the other two sinuses of Valsalva. In this study, to compensate for these differences in coronary anatomy, we opened the left coronary ostia toward the right to centralize the left sinus opening. The high right coronary artery still infrequently posed an alignment problem. This, in fact, may account for an increase in concomitant right coronary artery bypass grafting procedures in this study. We have subsequently learned that 120 rotation of the Freestyle valve has solved most of the coronary alignment problems. We now make the porcine noncoronary sinus the new left coronary sinus. The porcine left coronary sinus becomes the new right coronary sinus. Simply oversewing the porcine right coronary completes the new orientation of the porcine root. This maneuver readily allows the Freestyle valve to fit the human aortic root. Several studies with stentless valves intimate improved survival statistics after aortic valve replacement when compared to stented counterparts [21 23]. The true goal of aortic valve replacement in a patient with aortic valvular heart disease is to return that patient to both the lifestyle and the life expectancy of an age-matched patient without valvular heart disease. The high incidence of patients in New York Heart Association functional class I postoperatively in this study demonstrates significantly improved lifestyle. The superimposable natural life expectancy curve for a 72-year-old person with the survival of patients in this mean 72-year-old patient population demonstrates how close we are now coming to this goal (Fig 1). This is supporting evidence to continue using stentless porcine valves as root replacements for elderly patients with aortic valve and aortic root pathology. In conclusion, aortic root replacement is shown to be a safe replacement technique for aortic root and aortic valve pathology. Excellent valvular performance is ensured by optimal hemodynamics, perfect root geometry, no late aortic regurgitation, and no structural degeneration. Survival thus far is excellent and approaches that of an agematched population without valvular heart disease. Longer follow-up will help to determine true valve durability. Table 6. Mean Systolic Gradient and Effective Orifice Area for All Sizes Combined at Each Interval Examined Variable Discharge 3 6 mo 1 yr 2 yrs 3 yrs 4 yrs 5 yrs 6 yrs 7 yrs 8 yrs Mean systolic gradients (mm Hg) N Mean/SD Effective orifice area (cm 2 ) N Mean/SD
5 Ann Thorac Surg KON ET AL 2002;73: EIGHT-YEAR RESULTS WITH FREESTYLE PORCINE ROOT 1821 Fig 4. Incidence of aortic regurgitation after aortic root replacement. References 1. Yun KL, Jamieson WR, Khonsari S, Burr LH, Munro AI, Sintek CF. Prosthesis patient mismatch: hemodynamic comparison of stented and stentless aortic valves. Semin Thorac Cardiovasc Surg 1999;11(4 suppl 1): Kon ND, Adair SM, Kitzman DW, et al. Comparison of results using the Freestyle stentless porcine aortic root bioprosthesis with the cryopreserved aortic allograft. In: Huysmans HA, David TE, Westaby S, eds. Stentless bioprosthesis, 2nd ed. Oxford, United Kingdom: Isis Medical Media, 1999: Ennker J, Bauer J, Rosendahl U, et al. Simultaneous myocardial revascularization and aortic valve replacement: stentless versus stented bioprostheses. Semin Thorac Cardiovasc Surg 1999;11(4 suppl 1): Kon ND, Westaby S, Amarasena N, Pillai R, Cordell AR. Comparison of implant techniques using the Freestyle stentless porcine aortic valve. Ann Thorac Surg 1995;59: Doty DB, Cafferty A, Kon ND, Huysmans HA, Krause AH Jr, Westaby S. The Medtronic Freestyle Multicenter Clinical Trial Centers. Medtronic Freestyle aortic root bioprosthesis: implant techniques. J Cardiac Surg 1998;13: O Brien MP, McGriffin DC, Stafford EG. Allograft aortic valve implantation techniques for all types of aortic valve and root pathology. Ann Thorac Surg 1989;48: Daicoff GR, Botero LM, Quintessenza JA. Allograft replacement of the aortic valve versus the miniroot and valve. Ann Thorac Surg 1993;55: Kouchoukos NT, D Avila-Roman VG, Spray TL, et al. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med 1994;330: Elkins RC, Santangelo K, Stelzer P, et al. Pulmonary autograft replacement of the aortic valve: an evolution of technique. J Cardiac Surg 1992;7: Kon ND, Cordell AR, Adair SM, Dobbins JE, Kitzman, DW. Aortic root replacement with the Freestyle stentless porcine aortic root bioprosthesis. Ann Thorac Surg 1999; 67: David TE, Pollick C, Bos J. Aortic valve replacement with stentless porcine bioprosthesis. J Thorac Cardiovasc Surg 1990;99: Del Rizzo DF, Goldman BS, Joyner CP, et al. Initial clinical experience with the Toronto stentless porcine valve. J Cardiac Surg 1994;9: Westaby S, Amarasena N, Long V, et al. Time-related hemodynamic changes after aortic replacement with the Freestyle stentless xenograft. Ann Thorac Surg 1995;60: Cartier PC, Metras J, Dumesnil JG, et al. Clinical and hemodynamic performance of the Freestyle aortic root bioprosthesis. Ann Thorac Surg 1999;67: Doty DB, Cafferty A, Cartier P, et al. Aortic valve replacement with Medtronic Freestyle bioprosthesis: 5-year results. Semin Thorac Cardiovasc Surg 1999;11(4 suppl 1) Riley RD, Hammon JW Jr, Adair SM, Cordell AR, Kon ND. Stentless aortic valve replacement with Freestyle or Toronto SPV: an early comparison. Ann Thorac Surg 2000;70: David TE. Dilation of sinotubular junction: SPV bioprosthesis. Presented at The 81st annual AATS Plenary Scientific Session, San Diego, CA, May Bach DS, Cartier PA, Dumesnil JG, Kon ND, Doty DD. Impact of implant technique on clinical outcomes following freestyle stentless tissue aortic valve replacement - Presented at the American Heart Association Scientific Sessions Nov 2000: Lund O, Yacoub M, Chandrasekaran V, et al. Primary aortic valve determinants of outcome. J Thorac Cardiovasc Surg 1999;117: Melina G, Rubens MB, Amrani M, Khaghani A, Yacoub MH. Electron beam tomography for cusp calcification in homograft versus Freestyle xenografts. Ann Thorac Surg 2001; 71(5 suppl):s David TE, Puschmann R, Ivanov J, et al. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg 1998;116: Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. The effect of prosthetic valve type on survival after aortic valve surgery. Semin Thorac Cardiovasc Surg 1999;11(4 suppl 1): Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprosthesis. Ann Thorac Surg 2000;70: DISCUSSION DR W. STEVES RING (Dallas, TX): Dr Kon, these are excellent results. We are finally starting to see some of the long-term outcome with this new valve. Could you describe a little bit about your technique? Many of these patients have an extremely calcified annulus, frequently with calcium extending into the septum and the mitral annulus. Do you alter your technique for implanting the Freestyle bioprosthesis in the presence of a heavily calcified aortic annulus? DR KON: Initially, we thought that calcification around the coronaries and in the sinuses of Valsalva might be a contraindication to doing a root replacement. But what we actually found is that it is an indication to do a root replacement. What we do is try to clean up all of the calcium and excise all of the heavily diseased tissues. One of the beauties of doing a total root replacement in this setting is that you end up with excess tissue, therefore you do not end up with tension on any suture lines and you remove most, if not all, of the severely diseased tissues. We debride extensively everything and almost take out the entire annulus, if necessary, because we can seat the valve conduit a little bit lower in the left ventricular outflow tract when calcification in the annulus is extensive. If necessary, we have also endarterectomized the coronaries to reimplant them or left a larler rim of normal sinus of Valsalva tissue to aid in reimplantation. So, in summary, I believe the awful situation of extensive calcification can be handled quite nicely when using a root replacement technique.
The stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationStentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center experience of over 300 patients
European Journal of Cardio-thoracic Surgery 33 (2008) 554 559 www.elsevier.com/locate/ejcts Stentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationFunctional anatomy of the aortic root. ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη
Functional anatomy of the aortic root ΔΡΟΣΟΣ ΓΕΩΡΓΙΟΣ Διεσθσνηής Καρδιοθωρακοτειροσργικής Κλινικής Γ.Ν. «Γ. Παπανικολάοσ» Θεζζαλονίκη What is the aortic root? represents the outflow tract from the LV provides
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationSurgery for Acquired Cardiovascular Disease ACD
Surgery for Acquired Cardiovascular Disease Clinical outcomes after separate and composite replacement of the aortic valve and ascending aorta Thanos Sioris, MD Tirone E. David, MD Joan Ivanov, PhD Susan
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationThe Ross Procedure: Outcomes at 20 Years
The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:
More informationStentless aortic xenografts were introduced a decade
Survival After Stentless and Stented Xenograft Aortic Valve Replacement: A Concurrent, Controlled Trial Giovanni Battista Luciani, MD, Gianluca Casali, MD, Stefano Auriemma, MD, Francesco Santini, MD,
More informationStentless root bioprosthesis for repair of acute type A aortic dissection
ACQUIRED CARDIOVASCULAR DISEASE Stentless root bioprosthesis for repair of acute type A aortic dissection Craig R. Smith, MS, Sotiris C. Stamou, MD, PhD, Robert L. Hooker, MD, Charles C. Willekes, MD,
More informationEleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate
European Journal of Cardio-thoracic Surgery 22 (2002) 912 921 www.elsevier.com/locate/ejcts Eleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More informationStentless aortic valves. Current aspects
Endorsed by proceedings in Intensive Care Cardiovascular Anesthesia EXPERT OPINION HSR Proceedings in Intensive Care and Cardiovascular Anesthesia 2012; 4(2): 77-82 Stentless aortic valves. Current aspects
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationComposite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending aorta
European Journal of Cardio-thoracic Surgery 20 (2001) 252±256 www.elsevier.com/locate/ejcts Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending
More informationMedtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance
Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,
More informationThe increasing number of elderly patients with complex
Valved Stentless Composite Graft: Clinical Outcomes and Hemodynamic Characteristics Paul P. Urbanski, MD, Anno Diegeler, MD, Alexander Siebel, MD, Michael Zacher, MD, and Robert W. Hacker, MD Herz- und
More informationUse of Stentless Xenografts in the Aortic Position: Determinants of Early and Late Outcome
Use of Stentless Xenografts in the Aortic Position: Determinants of Early and Late Outcome A. Ruchan Akar, MD, Adam Szafranek, MD, Christos Alexiou, FRCS, Robert Janas, MD, Marek J. Jasinski, MD, Justiaan
More informationExperience with 500 Stentless Aortic Valve Replacements
Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More informationTranscatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,
Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationAortic valve replacement with a pulmonary autograft
Normalization of Left Ventricular Dimensions After Ross Operation With Aortic Annular Reduction Kazuo Niwaya, MD, Ronald C. Elkins, MD, Christopher J. Knott-Craig, MD, KathyLee Santangelo, MD, M. Bruce
More informationStentless Xenografts and Homografts for Right Ventricular Outflow Tract Reconstruction During the Ross Operation
Stentless Xenografts and Homografts for Right Ventricular Outflow Tract Reconstruction During the Ross Operation Franz X. Schmid, MD, Andreas Keyser, MD, Christoph Wiesenack, MD, Stefan Holmer, MD, and
More informationS ince the two large randomised trials of the 1970s
23 CARDIOVASCULAR MEDICINE Mid term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves I Florath, A Albert, U Rosendahl, T Alexander,
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationCoreValve in a Degenerative Surgical Valve
CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationThe Role Of Decellularized Valve Prostheses In The Young Patient
The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationDisease of the aortic valve is frequently associated with
Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities
More information15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationAortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients
Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Augusto D Onofrio, MD, Stefano Auriemma, MD, Paolo Magagna, MD, Alessandro Favaro, MD,
More informationValve prosthesis-patient mismatch (PPM) was first defined
Impact of Valve Prosthesis-Patient Mismatch on Short-Term Mortality After Aortic Valve Replacement Claudia Blais, BSc; Jean G. Dumesnil, MD; Richard Baillot, MD; Serge Simard, MS; Daniel Doyle, MD; Philippe
More informationAortic valve repair: Techniques and Pitfalls. Allan Stewart, MD Columbia University Medical Center New York, NY
Aortic valve repair: Techniques and Pitfalls Allan Stewart, MD Columbia University Medical Center New York, NY Take Away Points 1. Valve anatomy is essential to assess repair 2. Unique Decisions with Aneurysm/AI
More informationAnatomy determines the close vicinity of the sinuses of
Aortic Valve Reimplantation According to the David Type I Technique Matthias Karck, MD, and Axel Haverich, MD Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany.
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationRe-do aortic valve replacement after previous homograft aortic root replacement
Re-do aortic valve replacement after previous homograft aortic root replacement Jullien Gaer, Toufan Bahrami, Fabio de Robertis, Ahmed Abdulsalam, John Pepper, NHS Foundation Trust, UK Professor Sir Magdi
More informationCardiac Surgery A Resource of Experimental Design
Cardiac Surgery A Resource of Experimental Design Complete Transposition: a. Atrial switch the chronically systemic right ventricle b. Arterial switch the suddenly systemic left ventricle Fontan operation
More informationA Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision
A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction
More informationT sors in the following aspects: the porcine aortic valve
Clinical and Hemodynamic Assessment of the Hancock I1 Bioprosthesis Tirone E. David, MD, Susan Armstrong, MSc, and Zhao Sun, MA Division of Cardiovascular Surgery, The Toronto Hospital and University of
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More informationHemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves
Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes
More informationThe St. Jude Medical Biocor Bioprosthesis
The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year
More informationAortic valve repair: When and how to employ this novel approach?
Aortic valve repair: When and how to employ this novel approach? Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical
More informationA 20-year experience of 1712 patients with the Biocor porcine bioprosthesis
Acquired Cardiovascular Disease Mykén and Bech-Hansen A 2-year experience of 1712 patients with the Biocor porcine bioprosthesis Pia S. U. Mykén, MD, PhD, a and Odd Bech-Hansen, MD, PhD b Objective: The
More informationTHE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT
THE IMPACT OF AGE, CORONARY ARTERY DISEASE, AND CARDIAC COMORBIDITY ON LATE SURVIVAL AFTER BIOPROSTHETIC AORTIC VALVE REPLACEMENT Gideon Cohen, MD Tirone E. David, MD Joan Ivanov, MSc Sue Armstrong, MSc
More informationTen-Year Experience With Stentless Aortic Valves: Full-Root Versus Subcoronary Implantation
Ten-Year Experience With Stentless Aortic Valves: Full-Root Versus Subcoronary Implantation Juergen A. C. Ennker, MD, Alexander A. Albert, MD, Ulrich P. Rosendahl, MD, Ina C. Ennker, MD, Fatmir Dalladaku,
More informationAortic valve insufficiency may be caused by abnormalities
Reconstruction of the Ascending Aorta and Aortic Root: Experience in 45 Consecutive Patients Gebrine A. El Khoury, MD, Malcolm J. Underwood, MD, David Glineur, MD, David Derouck, MD, and Robert A. Dion,
More informationNew Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology
New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.
More informationAortic Regurgitation in Connective Tissue Disorders Special precautions? Carlos A. Mestres MD PhD FETCS
Aortic Regurgitation in Connective Tissue Disorders Special precautions? Carlos A. Mestres MD PhD FETCS Senior Consultant Department of Cardiovascular Surgery University Hospital Zürich (Switzerland) Extraordinary
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More informationDepartment of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden
Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart
More informationACD. Tirone E. David, MD, Christopher M. Feindel, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc
Replacement of the ascending aorta with reduction of the diameter of the sinotubular junction to treat aortic insufficiency in patients with ascending aortic aneurysm Tirone E. David, MD, Christopher M.
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More informationHow to Perform a Valve Sparing Root Replacement Joseph S. Coselli, M.D.
How to Perform a Valve Sparing Root Replacement Joseph S. Coselli, M.D. AATS International Cardiovascular Symposium 2017 Session 6: Technical Aspects of Open Surgery on the Aortic Valve Sao Paulo, Brazil
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationObtaining optimal hemodynamics after aortic valve
MULTICENTER STUDY OF STENTLESS VALVE REPLACEMENT IN THE SMALL AORTIC ROOT Ulrik Hvass, MD a George M. Palatianos, MD b Romeo Frassani, MD c Cesare Puricelli, MD c Mark O Brien, MD d Objective: A clinical
More informationAortic Valve Resuspension in Ascending Aortic Aneurysm Repair With Aortic Insufficiency
Aortic Valve Resuspension in Ascending Aortic Aneurysm Repair With Aortic Insufficiency Paul Simon, MD, Anton Mortiz, MD, Reinhard Moidl, MD, Natascha Kupilik, MD, Martin Grabenwoeger, MD, Marek Ehrlich,
More informationNARRATOR NEAL KON, M.D.
FREESTYLE STENTLESS PORCINE AORTIC ROOT BIOPROSTHESIS WAKE FOREST UNIVERSITY BAPTIST MEDICAL CENTER WINSTON SALEM, NORTH CAROLINA Broadcast January 13, 2004 NARRATOR When Carey Laniere s defective heart
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationWill we face a big problem with the aortic valve/root after ASO?
Will we face a big problem with the aortic valve/root after ASO? Laurence Iserin Unité médico-chirurgicale de Cardiologie Congénitale Adulte Hôpital Universitaire Européen Georges Pompidou APHP, Université
More informationMedium-Term Determinants of Left Ventricular Mass Index After Stentless Aortic Valve Replacement
Medium-Term Determinants of Left Ventricular Mass Index After Stentless Aortic Valve Replacement Xu Y. Jin, MD, PhD, Ravi Pillai, FRCS, and Stephen Westaby, FRCS Department of Cardiac Surgery, Oxford Heart
More informationProsthetic valve dysfunction: stenosis or regurgitation
Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in
More informationGeometric mismatch between homograft (allograft) and native aortic root: a 14-year clinical experience q
European Journal of Cardio-thoracic Surgery 20 (2001) 835 841 www.elsevier.com/locate/ejcts Geometric mismatch between homograft (allograft) and native aortic root: a 14-year clinical experience q A.C.
More informationAortic Root Replacement Using an Allograft for Active Infective Endocarditis With Periannular Abscess: Single Center Experience
J Cardiol 2004 Jun; 436: 267 271 : Aortic Root Replacement Using an Allograft for Active Infective Endocarditis With Periannular Abscess: Single Center Experience Kazuhito Shunei Shinichi Noboru Sakiko
More informationProf. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM
The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?
More informationAutograft or Allograft Aortic Root Replacement in Children and Young Adults With Aortic Valve Disease: A Single-Center Comparison
Autograft or Allograft Aortic Root Replacement in Children and Young Adults With Aortic Valve Disease: A Single-Center Comparison Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J. Shah, MD, and Randall
More informationPROSTHETIC VALVE BOARD REVIEW
PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve
More informationAortic stenosis is the most common acquired heart valve. The Toronto Root Bioprosthesis: Midterm Results in 186 Patients
The Toronto Root Bioprosthesis: Midterm Results in 186 Patients Sven Lehmann, MD, Thomas Walther, MD, PhD, Sergey Leontyev, MD, Jörg Kempfert, MD, Jens Garbade, MD, Michael A. Borger, MD, PhD, and Friedrich
More informationP have been used for mitral and aortic valve replacement
A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,
More informationMIDTERM RESULTS AFTER AORTIC VALVE REPLACEMENT WITH FREEHAND STENTLESS XENOGRAFTS: A COMPARISON OF THREE PROSTHESES
MIDTERM RESULTS AFTER AORTIC VALVE REPLACEMENT WITH FREEHAND STENTLESS XENOGRAFTS: A COMPARISON OF THREE PROSTHESES Giovanni Battista Luciani, MD Paolo Bertolini, MD Barbara Vecchi, MD Alessandro Mazzucco,
More informationNineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up
Nineteen-Millimeter Aortic St. Jude Medical Heart Valve Prosthesis: Up to Sixteen Years Follow-up Dilip Sawant, FRCS, Arun K. Singh, MD, William C. Feng, MD, Arthur A. Bert, MD, and Fred Rotenberg, MD
More informationSurgical Procedures and Complications
Radiological Society of North America, RSNA 2013 Refresher Course Program: Vascular Track Surgical Procedures and Complications Learning objectives Outline RC 112 : Key Concepts: Surgical Procedures and
More information-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD
-The Living Aortic Valve- Repair or Else? Ismail El-Hamamsy, MD PhD Associate Professor Director, Aortic Surgery Division of Cardiac Surgery Montreal Heart Institute Université de Montreal PhD Thesis Imperial
More informationResults of Aortic Valve Preservation and Repair
Results of Aortic Valve Preservation and Repair Department of Cardiothoracic and Vascular Surgery Cliniques Universitaires St. Luc Brussels, Belgium Gebrine Elkhoury Institutional experience in AV preservation
More informationAortic root reconstructive surgery - new created technique for aortic stenosis
Aortic root reconstructive surgery - new created technique for aortic stenosis Reconstructive surgery of the aortic root Academician d-r Zan Mitrev, T.Anguseva, E.Stoicovski, E Idoski Special hospital
More informationValve-sparing aortic root replacement in patients with Marfan syndrome the Homburg experience
Masters of Cardiothoracic Surgery Valve-sparing aortic root replacement in patients with Marfan syndrome the Homburg experience Ulrich Schneider, Tristan Ehrlich, Irem Karliova, Christian Giebels, Hans-Joachim
More informationHani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.
Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility
More informationHypoplasia of the aortic root1 The problem of aortic valve replacement
Hypoplasia of the aortic root1 The problem of aortic valve replacement ROWAN NICKS, T. CARTMILL, and L. BERNSTEIN Department of Cardio-thoracic Surgery and the Hallstrom Institute of Cardiology, the Royal
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationAortic valve calcium load before TAVI: Is it important?
Research Highlight Aortic valve calcium load before TAVI: Is it important? Martin Haensig 1, Ardawan Julian Rastan 2 1 Department of Cardiac Surgery, Heart Center, University of Leipzig, Germany; 2 Department
More informationComparative Rest and Exercise Hemodynamics of 23-mm Stentless Versus 23-mm Stented Aortic Bioprostheses
Comparative Rest and Exercise Hemodynamics of 23-mm Stentless Versus 23-mm Stented Aortic Bioprostheses Roland Fries, MD, Olaf Wendler, MD, Hermann Schieffer, MD, and Hans-Joachim Schäfers, MD, PhD Departments
More informationRoss introduced the replacement of a diseased aortic. The Ross Operation: An Evaluation of a Single Institution s Experience
The Ross Operation: An Evaluation of a Single Institution s Experience Fabrizio Settepani, MD Abdullah Kaya, MD, Wim J. Morshuis, MD, PhD, Marc A. Schepens, MD, PhD, Robin H. Heijmen, MD, PhD, and Karl
More informationAORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION
AORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION Jacques A. M. van Son, MD, PhD Roberto Battellini, MD Marco Mierzwa,
More informationEmergency Intraoperative Echocardiography
Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will
More informationAppropriate Use of TAVR - now and in the future. A Surgeon s Perspective. Neil Moat Royal Brompton Hospital, London, UK
Appropriate Use of TAVR - now and in the future A Surgeon s Perspective Neil Moat Royal Brompton Hospital, London, UK Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner
More informationRole of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,
Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, transplantation and Vascular Surgery Hannover Medical School, Germany
More informationEffect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,
More informationEvolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa
Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa Charles Hufnagel developed and successfully implanted the first prosthetic cardiac valve in the descending thoracic aorta
More informationHemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve
Hemodynamics and Early Clinical Performance of the St. Jude Medical Regent Mechanical Aortic Valve David S. Bach, MD, Marc P. Sakwa, MD, Martin Goldbach, MD, Michael R. Petracek, MD, Robert W. Emery, MD,
More informationCase. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)
Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More information